Sign InBreakout Stocks of Week 11 @ XLON
NASDAQ was down last week (week 10) by -1.24% ending at 22,387.68 points after falling -280.53 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Serco Group plc XLON:SRP. This stock has had a buy signal since Mar 05, 2026 when the price was 306.00p and is so far up 1.24% to 309.80p. Some other companies are on our watchlist to, among these are Xtrackers Msci Ac Asia Ex Japan Esg Swap Ucits Etf XLON:XAXD The European Smaller Companies Trust Plc XLON:ESCT PureTech Health Plc XLON:PRTC and Xtrackers Ii Global Government Bond Ucits Etf XLON:XGSG which all got a breakout pattern emerging.
| Date | Company | Price | Week 11 |
|---|---|---|---|
| Serco Group Plc | 309.80p | 320.20p | 3.36% |
| Xtrackers Msci Ac Asia Ex Japan Esg Swap Ucits Etf | $58.63 | $58.74 | 0.188% |
| The European Smaller Companies Trust Plc | 213.50p | 210.00p | -1.64% |
| Puretech Health Plc | 123.60p | 121.20p | -1.94% |
| Xtrackers Ii Global Government Bond Ucits Etf | 2,410.50p | 2,383.07p | -1.14% |
The Serco Group plc stock price gained 1.24% on the last trading day (Friday, 6th Mar 2026), rising from 306.00p to 309.80p. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 2.89% from a day low at 304.40p to a day high of 313.20p. The price has risen in 6 of the last 10 days and is up by 3.68% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 70 thousand more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately 943.49p million.
Serco Group plc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
About Serco Group plc:
Serco Group plc provides public services in the United Kingdom, Europe, North America, the Asia Pacific, and the Middle East. The company offers base and operational support engineering, and management and information, as well as nuclear, space, and maritime services for the defense sector; and custodial, immigration detention, and detainee transport and monitoring services for the justice and immigration sectors. It also provides rail, ferry, and cycle operations; road traffic management; and air traffic control services to the transportation sector, as well as integrated facilities management, pathology and non-clinical support, and patient administration and contact services for the health sector. In addition, the company offers citizen services, including contact centers and case management; middle, back office, and IT; and employment and skills services. The company serves the United Kingdom and Canadian governments, devolved authorities, and other public sector customers; and federal and civilian agencies, and various state and municipal governments. Serco Group plc was founded in 1929 and is based in Hook, the United Kingdom.
The Xtrackers Msci Ac Asia Ex Japan Esg Swap ETF price gained 0.83% on the last trading day (Friday, 6th Mar 2026), rising from $58.15 to $58.63. During the last trading day the ETF fluctuated 2.43% from a day low at $57.99 to a day high of $59.40. The price has fallen in 7 of the last 10 days and is down by -7.28% for this period. Volume fell on the last day by -7 thousand shares and in total, 163 thousand shares were bought and sold for approximately $9.55 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
The The European Smaller Companies Trust Plc trust price fell by -0.466% on the last day (Friday, 6th Mar 2026) from 214.50p to 213.50p. During the last trading day the trust fluctuated 2.13% from a day low at 211.50p to a day high of 216.00p. The price has fallen in 6 of the last 10 days and is down by -4.47% for this period. Volume has increased on the last day by 302 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 702 thousand shares were bought and sold for approximately 149.84p million.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
The PureTech Health Plc stock price fell by -0.80% on the last day (Friday, 6th Mar 2026) from 124.60p to 123.60p. During the last trading day the stock fluctuated 2.62% from a day low at 122.00p to a day high of 125.20p. The price has fallen in 6 of the last 10 days and is down by -2.68% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -78 thousand shares and in total, 212 thousand shares were bought and sold for approximately 26.19p million.
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for PureTech Health Plc stock to perform well in the short-term period.
About PureTech Health Plc:
PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholine receptors to treat schizophrenia and psychosis in Alzheimer's disease; a regenerative biology platform for androgenetic alopecia, epithelial ageing, and other medical conditions; an immunomodulation platform to treat chronic and acute inflammatory disorders; oral therapies based on defined consortia of bacteria is isolated from the human microbiome; and therapies to treat cognitive dysfunction associated with depression, multiple sclerosis, post COVID and ICU, and cancer related conditions. It also provides hematopoietic stem cell based therapies for patients with blood cancer; a voice-based technology platform to detect voice changes linked to health conditions; and a technology platform for the oral delivery of biologics, vaccines, and other drugs. In addition, the company is developing LYT-100 to treat lymphedema, and other lymphatic flow disorders; LYT-200, a IgG4 monoclonal antibody to target galectin-9; LYT-210 to treat solid tumors; Glyph, a synthetic lymphatic targeting chemistry platform; Orasome technology to enable the oral administration of macromolecule therapeutic payloads; meningeal lymphatics platform to treat Alzheimer's and Parkinson's diseases; and Alivio technology platform for inflammation-targeted disease immunomodulation. PureTech Health plc has collaboration and license agreements with Boehringer Ingelheim International GMBH; Eli Lilly and Company; Imbrium Therapeutics L.P.; and Shionogi & Co., Ltd. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
The Xtrackers Ii Global Government Bond ETF price gained 0.0830% on the last trading day (Friday, 6th Mar 2026), rising from 2,408.50p to 2,410.50p. During the last trading day the ETF fluctuated 0.794% from a day low at 2,391.50p to a day high of 2,410.50p. The price has risen in 6 of the last 10 days but is still down by -0.21% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 9 thousand more shares were traded than the day before. In total, 13 thousand shares were bought and sold for approximately 31.22p million.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
GOLDEN STAR
| Ticker | Change | Signal Date |
|---|---|---|
IDYA
$28.98
|
7.76% | Jun 12 |
DHI
$146.71
|
7.57% | Jun 10 |
PHM
$118.49
|
7.15% | Jun 10 |
EAT
$140.46
|
17.39% | Jun 05 |
TPR
$140.47
|
2.16% | Jun 04 |
